My Heart and CKD: A Shared Decision Aid to Help CKD and CAD Patients Choose Heart Procedures
Official title: Feasibility and Pilot Testing of the "My Heart and CKD" Online Shared Decision Aid
Run by University of Calgary · NCT06920927 · Data updated 2026-11-12
A patient-focused online tool tests whether a personalized decision aid can help adults with chronic kidney disease and coronary artery disease make informed choices about heart procedures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Locations | 2 sites (Calgary, Alberta and 1 other locations) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | April 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT06920927 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with chronic kidney disease and coronary artery disease who can communicate in English or French (or via a bilingual caregiver) and have cognitive capacity or a surrogate to participate in shared decision making.
✕Probably not a fit
Patients with end-stage kidney failure on dialysis, ST-elevation myocardial infarction, or those not expected to survive to hospital discharge may not benefit from the decision aid in its current form.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study explores a patient-facing online decision aid designed to present personalized benefits and risks of heart procedures for people with chronic kidney disease and coronary artery disease. The tool aims to support shared decision making between patients and clinicians by aligning treatment options with patient values and local practice patterns. The study targets adults with CKD and CAD who speak English or French, and uses a feasibility/pilot framework to refine user experience and information delivery. Enrollment is based on specific CKD and CAD criteria, with safety and usability endpoints guiding potential scale-up if successful.
Why it matters
Potential benefit: If successful, patients may make more informed choices that reflect their values and risk tolerance, potentially improving satisfaction and alignment of care with personal goals.
How similar studies have gone: Previous work in CKD and CAD has shown that decision aids can support personalized risk communication and shared decision making, though results vary by setting and implementation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (18 years of age or older) * Chronic kidney disease * Coronary artery disease (non-ST elevation acute coronary syndrome (ACS) or symptoms or signs of stable coronary heart disease) * Able to communicate in English or French or through a support person who speaks English or French * Patient has the cognitive ability or has a surrogate decision maker capable of participating in shared decision making based on the discretion of the attending physician Exclusion Criteria: * End stage kidney failure already being treated with dialysis or with an eGFR \< 10mL/min/1.73m2 * ST-elevation myocardial infarction * Patient is not expected to survive to hospital discharge
Where it's running
-
Foothills Medical Centre
Calgary, Alberta, Canada Recruiting -
University of Alberta Hospital
Edmonton, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Matthew T James, MD — University of Calgary
- Study coordinator: Pantea Javaheri, MRSc
- Email: pantea.javaheri@ucalgary.ca
- Phone: 1 (403) 220 2465
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored hydration using ReDS lung‑water monitoring to prevent kidney injury during coronary angiography and intervention
This trial tests whether using a ReDS lung‑water monitor to guide IV fluids can lower the risk of contrast‑induced acute kidney injury in people aged 60 and older with reduced kidney function having coronary angiography or PCI.
-
Managing multiple medications in older adults with chronic diseases
This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.